Avid bioservices, inc. (CDMO)
Income statement / Yearly
Apr'19Apr'18Apr'17Apr'16Apr'15Apr'14Apr'13Apr'12Apr'11Apr'10
Contract manufacturing revenue

-

-

-

-

26,744

22,294

21,333

14,783

8,502

13,204

Government contract revenue

-

-

-

-

-

-

-

-

4,640

14,496

License revenue

-

-

-

-

37

107

350

450

350

243

Revenues

53,603

53,621

57,630

44,357

26,781

22,401

21,683

15,233

13,492

27,943

Cost of revenues

46,379

56,545

38,259

22,966

-

-

-

-

-

-

Cost of contract manufacturing

-

-

-

-

15,593

13,110

12,595

10,153

7,296

8,716

Gross profit

7,224

-2,924

19,371

21,391

-

-

-

-

-

-

Operating expenses:
Selling, general and administrative

12,846

16,456

18,079

17,904

18,691

17,274

13,134

11,462

11,421

8,182

Research and development

-

-

-

-

42,996

27,723

24,306

35,688

29,462

24,658

Restructuring charges

0

1,258

0

0

-

-

-

-

-

-

Total operating expenses

12,846

17,714

18,079

17,904

77,280

58,107

50,035

57,303

48,179

41,556

Operating loss

-5,622

-20,638

1,292

3,487

-50,499

-35,706

-28,352

-42,070

-34,687

-13,613

Interest and other income, net

282

75

101

124

142

349

322

41

1,052

116

Interest and other expense

-

-

-

-

-

-

54

90

516

997

Interest and other expense

-

-

-

14

1

5

-

-

-

-

Loss from continuing operations before income taxes

-5,340

-20,563

1,393

3,597

-

-

-

-

-

-

Income tax benefit

-284

0

0

-

-

-

-

-

-

-

Loss from continuing operations, net of tax

-5,056

-20,563

1,393

-

-

-

-

-

-

-

Income from discontinued operations, net of tax

841

-1,250

-29,552

-59,249

-

-

-

-

-

-

Loss on early extinguishment of debt

-

-

-

-

-

-

-1,696

0

0

-

Net Loss

-4,215

-21,813

-28,159

-55,652

-50,358

-35,362

-29,780

-42,119

-34,151

-14,494

Comprehensive loss

-4,215

-21,813

-28,159

-55,652

-50,358

-35,362

-29,780

-42,119

-34,151

-

Series E preferred stock accumulated dividends

4,686

4,686

4,640

4,484

3,696

401

0

0

-

-

Net loss attributable to common stockholders

-8,901

-26,499

-32,799

-60,136

-54,054

-35,763

-29,780

-42,119

-

-

Basic and diluted net (loss) income per common share attributable to common stockholders: Continuing Operations

-0.17

-0.53

-0.09

-0.03

-

-

-

-

-

-

Basic and diluted net (loss) income per common share attributable to common stockholders: Discontinued Operations

0.01

-0.03

-0.79

-1.92

-

-

-

-

-

-

Net loss per common share attributable to common stockholders

-0.16

-0.56

-0.88

-1.95

-2.07

-0.22

-0.25

-0.50

-0.56

-0.30

Weighted average basic and diluted shares outstanding

55,981

47,063

37,109

30,895

26,079

161,579

120,370

83,572

60,886

49,065